These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36949800)

  • 21. Directional Stimulation in Parkinson's Disease and Essential Tremor: The Cleveland Clinic Experience.
    Rammo RA; Ozinga SJ; White A; Nagel SJ; Machado AG; Pallavaram S; Cheeran BJ; Walter BL
    Neuromodulation; 2022 Aug; 25(6):829-835. PubMed ID: 33733515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain impedance variation of directional leads implanted in subthalamic nuclei of Parkinsonian patients.
    Eleopra R; Rinaldo S; Devigili G; Lettieri C; Mondani M; D'Auria S; Piacentino M; Pilleri M
    Clin Neurophysiol; 2019 Sep; 130(9):1562-1569. PubMed ID: 31301634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directional Local Field Potentials in the Subthalamic Nucleus During Deep Brain Implantation of Parkinson's Disease Patients.
    Nguyen TAK; Schüpbach M; Mercanzini A; Dransart A; Pollo C
    Front Hum Neurosci; 2020; 14():521282. PubMed ID: 33192384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Directional Deep Brain Stimulation on Sensory Thresholds in Parkinson's Disease.
    Sabourin S; Khazen O; DiMarzio M; Staudt MD; Williams L; Gillogly M; Durphy J; Hanspal EK; Adam OR; Pilitsis JG
    Front Hum Neurosci; 2020; 14():217. PubMed ID: 32581755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic Directional Deep Brain Stimulation for tremor: Spend less, get more.
    Rebelo P; Green AL; Aziz TZ; Kent A; Schafer D; Venkatesan L; Cheeran B
    Brain Stimul; 2018; 11(3):600-606. PubMed ID: 29373260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Clinical Experience with Directional Deep Brain Stimulation Programming: A Retrospective Review.
    Karl JA; Joyce J; Ouyang B; Verhagen Metman L
    Neurol Ther; 2022 Sep; 11(3):1309-1318. PubMed ID: 35776383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.
    Schnitzler A; Mir P; Brodsky MA; Verhagen L; Groppa S; Alvarez R; Evans A; Blazquez M; Nagel S; Pilitsis JG; Pötter-Nerger M; Tse W; Almeida L; Tomycz N; Jimenez-Shahed J; Libionka W; Carrillo F; Hartmann CJ; Groiss SJ; Glaser M; Defresne F; Karst E; Cheeran B; Vesper J;
    Neuromodulation; 2022 Aug; 25(6):817-828. PubMed ID: 34047410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus.
    Nguyen TAK; Djilas M; Nowacki A; Mercanzini A; Schüpbach M; Renaud P; Pollo C
    PLoS One; 2019; 14(6):e0217985. PubMed ID: 31216311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Directions in Deep Brain Stimulation for Parkinson's Disease-Directing Current to Maximize Clinical Benefit.
    Merola A; Romagnolo A; Krishna V; Pallavaram S; Carcieri S; Goetz S; Mandybur G; Duker AP; Dalm B; Rolston JD; Fasano A; Verhagen L
    Neurol Ther; 2020 Jun; 9(1):25-41. PubMed ID: 32157562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Field Potential-Guided Contact Selection Using Chronically Implanted Sensing Devices for Deep Brain Stimulation in Parkinson's Disease.
    Strelow JN; Dembek TA; Baldermann JC; Andrade P; Jergas H; Visser-Vandewalle V; Barbe MT
    Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Waldthaler J; Bopp M; Kühn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
    Brain Stimul; 2021; 14(5):1109-1117. PubMed ID: 34352356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiparkinsonian Drug Reduction After Directional Versus Omnidirectional Bilateral Subthalamic Deep Brain Stimulation.
    Pintér D; Járdaházi E; Balás I; Harmat M; Makó T; Juhász A; Janszky J; Kovács N
    Neuromodulation; 2023 Feb; 26(2):374-381. PubMed ID: 35190245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High resolution transcranial acoustoelectric imaging of current densities from a directional deep brain stimulator.
    Preston C; Alvarez AM; Barragan A; Becker J; Kasoff WS; Witte RS
    J Neural Eng; 2020 Feb; 17(1):016074. PubMed ID: 31978914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards guided and automated programming of subthalamic area stimulation in Parkinson's disease.
    Xu SS; Sinclair NC; Bulluss KJ; Perera T; Lee WL; McDermott HJ; Thevathasan W
    Brain Commun; 2022; 4(1):fcac003. PubMed ID: 35169708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept.
    Nguyen TAK; Nowacki A; Debove I; Petermann K; Tinkhauser G; Wiest R; Schüpbach M; Krack P; Pollo C
    Brain Stimul; 2019; 12(5):1127-1134. PubMed ID: 31130498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Directional DBS increases side-effect thresholds-A prospective, double-blind trial.
    Dembek TA; Reker P; Visser-Vandewalle V; Wirths J; Treuer H; Klehr M; Roediger J; Dafsari HS; Barbe MT; Timmermann L
    Mov Disord; 2017 Oct; 32(10):1380-1388. PubMed ID: 28843009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.
    Bouthour W; Béreau M; Kibleur A; Zacharia A; Tomkova Chaoui E; Fleury V; Benis D; Momjian S; Bally J; Lüscher C; Krack P; Burkhard PR
    Mov Disord; 2019 Nov; 34(11):1728-1734. PubMed ID: 31571277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Programming Features Help Alleviate Subthalamic Nucleus Stimulation-Induced Side Effects.
    Dayal V; De Roquemaurel A; Grover T; Ferreira F; Salazar M; Milabo C; Candelario-McKeown J; Zrinzo L; Akram H; Limousin P; Foltynie T
    Mov Disord; 2020 Dec; 35(12):2261-2269. PubMed ID: 32979290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directional deep brain stimulation: an intraoperative double-blind pilot study.
    Pollo C; Kaelin-Lang A; Oertel MF; Stieglitz L; Taub E; Fuhr P; Lozano AM; Raabe A; Schüpbach M
    Brain; 2014 Jul; 137(Pt 7):2015-26. PubMed ID: 24844728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.